Latest Strategic Shift News

Loyal Lithium unveils a strategic pivot to broaden its North American lithium and battery technology portfolio, leveraging new US energy policies and $5.5 million in funding to capitalize on the continent’s evolving energy grid demands.

News Corporation reported a robust second quarter for Fiscal 2025, with revenues climbing 5% to $2.24 billion and net income soaring 58%, while announcing the strategic sale of Foxtel to DAZN for A$3.4 billion.

Blackstone Minerals Limited has requested an immediate voluntary suspension of its shares as it finalises a proposed merger, signaling a significant strategic shift for the mining company.

Hartshead Resources has submitted a revised development report to the NSTA, unveiling a superior gas export route through CalEnergy's Saturn Banks pipeline that promises reduced costs and faster production.

Canyon Resources announces Peter Secker as new CEO, signaling a strategic shift as the company advances its Minim Martap bauxite project toward production.

5G Networks Limited has extended its on-market takeover offer for AuCyber Limited shares, prolonging the bid period to mid-February 2025. This move signals continued strategic interest amid a competitive acquisition landscape.

OM Holdings Limited has reported a strong finish to FY24 with production volumes surpassing guidance and outlined robust production targets for FY25 amid shifting market dynamics in ferrosilicon and manganese.

Althea Group Holdings Limited has had its trading suspension lifted following a Federal Court ruling related to cleansing notice lodgement failures, marking a key regulatory milestone for the pharmaceutical company.

Newfield Resources Limited reports a strategic pivot for its Tongo Diamond Mine, engaging a joint development partner to reduce costs and delay bulk sampling amid a depressed diamond market.

Thrive Tribe Technologies has strengthened its cash position through multiple capital raises and appointed Jade Spooner as its new CEO, while its Slik investment achieved profitability in Q4 2024.

Argent BioPharma reports strategic cost-cutting moves including facility closures and delisting from the LSE, while securing German distribution approval and raising significant capital to support its drug pipeline.

AssetOwl Limited has appointed new directors and secured a $300,000 loan facility as it undertakes a strategic review to revive shareholder value amid a quiet quarter.